The Fourth Affiliated Hospital of Harbin Medical University
10
1
1
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
20%
2 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
The Efficacy and Safety of Pregabalin and Crisugabalin in Patients With Fibromyalgia
Role: collaborator
A Multimodal Predictive Recurrence Score for Patients With Clear Cell Renal Cell Carcinoma
Role: collaborator
Calculator Predicts Early Mortality Post Hepatocellular Carcinoma Resection
Role: collaborator
SPT-07A Injection in Patients With Acute Ischemic Stroke (AIS): A Phase III Clinical Trial
Role: collaborator
Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study
Role: collaborator
Multifactorial Intervention on Diabetes (MIDiab Study)
Role: collaborator
Epidemiological Survey of Hepatitis D Virus Infection in China
Role: collaborator
Circulating Tumor DNA Methylation Test to Differentiate Benign and Malignant Pulmonary Nodules
Role: collaborator
The Study of Active Transfer of Plaque Technique for Unprotected Distal Left Main Bifurcation Lesions
Role: collaborator
Epidemiological Study of Iron Deficiency and Iron Deficiency Anemia in Chinese Pregnant Women
Role: collaborator
All 10 trials loaded